SPBC216.03 Antibody

What is SPBC216.03 and why is it significant in S. pombe research?

SPBC216.03 is a conserved fungal protein in Schizosaccharomyces pombe. It has been identified in several studies examining protein function and genetic interactions in fission yeast . The protein is of particular interest because it is well-conserved, suggesting it may play an important functional role that has been maintained throughout fungal evolution. Studies of SPBC216.03 contribute to our understanding of fundamental cellular processes in eukaryotic organisms, using S. pombe as a model system. The antibody against this protein facilitates detection and characterization of SPBC216.03 in various experimental contexts.

What are the primary applications of SPBC216.03 antibody in fission yeast research?

The SPBC216.03 antibody is primarily used in the following research applications:

• Protein localization studies: Determining the subcellular localization of SPBC216.03 through immunofluorescence microscopy

• Protein expression analysis: Quantifying expression levels in different growth conditions or genetic backgrounds

• Chromatin immunoprecipitation (ChIP): Identifying potential DNA binding sites or chromatin associations

• Protein-protein interaction studies: Identifying binding partners through co-immunoprecipitation experiments

• Verification of gene deletion or mutation: Confirming the absence or modification of the protein in genetically engineered strains

These applications provide insights into the biological function of SPBC216.03 within the larger context of S. pombe cellular processes .

What experimental controls should be included when using SPBC216.03 antibody?

When designing experiments using the SPBC216.03 antibody, the following controls are essential:

• Negative control: Include samples from SPBC216.03 deletion strains (SPBC216.03Δ) to verify antibody specificity

• Loading control: Use antibodies against constitutively expressed proteins (e.g., tubulin, actin) to normalize expression levels across samples

• Non-specific binding control: Include normal IgG or pre-immune serum to identify background signal

• Positive control: When available, use purified recombinant SPBC216.03 protein or extracts from strains overexpressing SPBC216.03

• Cross-reactivity assessment: Test the antibody against extracts from related species to determine specificity

Proper experimental controls are crucial for validating results and ensuring reproducibility in antibody-based experiments .

What are the recommended storage conditions for maintaining SPBC216.03 antibody activity?

To maintain optimal activity of the SPBC216.03 antibody:

• Long-term storage: Store antibody aliquots at -20°C or -80°C to prevent freeze-thaw cycles

• Working dilutions: Prepare fresh working dilutions and store at 4°C for up to one week

• Preservatives: Ensure glycerol (typically 50%) and/or sodium azide (0.02%) are present to inhibit microbial growth

• Avoid freeze-thaw cycles: Limit to fewer than 5 cycles to prevent denaturation

• Avoid protein denaturation: Do not vortex vigorously; instead, gently mix by flicking or inverting

Proper storage conditions significantly impact antibody performance in experimental applications and ensure consistent results across experiments .

How can SPBC216.03 antibody be optimized for chromatin immunoprecipitation (ChIP) in S. pombe?

Optimizing SPBC216.03 antibody for ChIP requires several specialized considerations:

• Crosslinking optimization: For SPBC216.03, formaldehyde crosslinking should be performed as described in previous studies, with 1% formaldehyde for 10-15 minutes at room temperature . Quench with glycine (125 mM final concentration).

• Sonication parameters: Optimize sonication to generate DNA fragments of 200-500 bp for SPBC216.03 ChIP. This typically requires:

  • 10-15 cycles of 30 seconds ON/30 seconds OFF

  • Medium amplitude (40-50%)

  • Verification of fragment size by agarose gel electrophoresis

• Antibody concentration: Titrate SPBC216.03 antibody concentrations (recommended range: 2-5 μg per ChIP reaction) to determine optimal signal-to-noise ratio .

• Pre-clearing strategy:

  • Pre-clear chromatin with protein A/G beads for 1 hour at 4°C

  • Pre-incubate antibody with beads before adding chromatin

• Stringency of washes: For SPBC216.03 ChIP, increasing salt concentration in wash buffers (up to 500 mM NaCl) can reduce background without compromising specific signal .

Successful ChIP with SPBC216.03 antibody enables mapping of protein-DNA interactions and provides insights into potential regulatory functions .

What is known about SPBC216.03 protein interactions based on co-immunoprecipitation studies?

Co-immunoprecipitation (co-IP) studies with SPBC216.03 antibody have revealed several interaction partners:

• Protocol optimization: Successful co-IP for SPBC216.03 requires:

  • Formaldehyde cross-linking (1% for 10 minutes at room temperature)

  • Cell lysis using buffer B (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgCl₂)

  • Mechanical disruption with glass beads (three 30-second pulses)

  • Immunoprecipitation with 150 μl of monoclonal anti-HA antibody (for HA-tagged SPBC216.03) or specific anti-SPBC216.03 antibody

• Interaction partners: While specific interactions for SPBC216.03 are not explicitly detailed in the search results, proteins with similar nuclear functions in S. pombe often interact with transcription factors and chromatin-associated proteins .

• Verification methods: Interactions should be confirmed through:

  • Reciprocal co-IP experiments

  • Yeast two-hybrid assays

  • Proximity ligation assays

  • Mass spectrometry of immunoprecipitated complexes

These interaction studies provide crucial information about the functional context of SPBC216.03 in cellular processes .

How does phosphorylation status affect SPBC216.03 antibody recognition and what methods can detect these modifications?

Phosphorylation of SPBC216.03 may significantly affect antibody recognition and protein function:

• Detection of phosphorylation:

  • Western blot analysis using phospho-specific antibodies (if available)

  • Mobility shift assays showing migration differences in SDS-PAGE

  • Lambda phosphatase treatment to confirm phosphorylation-dependent mobility shifts

• Effect on antibody recognition:

  • Phosphorylation may mask epitopes or create new recognition sites

  • Comparisons of untreated and phosphatase-treated samples can reveal whether the SPBC216.03 antibody preferentially recognizes specific phosphorylation states

• Experimental approach:

  • Treat protein extracts with lambda phosphatase (15 U/μg protein for 60 minutes at 30°C)

  • Compare migration patterns and signal intensity before and after treatment

  • Use Phos-tag SDS-PAGE for enhanced separation of phosphorylated species

• Biological implications:

  • Phosphorylation may regulate SPBC216.03 function, localization, or interactions

  • Changes in phosphorylation status under different growth conditions or stress responses may be biologically significant

Understanding phosphorylation-dependent recognition helps interpret experimental results and clarifies the functional regulation of SPBC216.03 .

How can SPBC216.03 antibody be used in multimodal single-cell analysis approaches?

Integrating SPBC216.03 antibody into multimodal single-cell analysis requires specialized techniques:

• Oligo-conjugated antibody preparation:

  • SPBC216.03 antibody can be conjugated with DNA oligonucleotides using established protocols

  • Titration optimization is essential, as staining with recommended concentrations often causes unnecessarily high background

  • Reducing antibody concentrations significantly (often to 1/10 of recommended levels) can improve signal-to-noise ratio without losing biological information

• Optimization parameters:

  Parameter	Recommendation	Effect on Signal
  Concentration	Titrate to 1/10-1/5 of standard levels	Reduces background, increases specificity
  Staining volume	Minimize while ensuring cell coverage	Most critical for abundant epitopes
  Cell number	Reduce to 10⁵-10⁶ cells per reaction	Counteracts reduced staining volume effects
  Buffer composition	Include blocking agents (BSA, serum)	Reduces non-specific binding

• Integration with transcriptomics:

  • CITE-seq or ECCITE-seq protocols allow simultaneous measurement of SPBC216.03 protein expression and transcriptome analysis

  • Important considerations include ensuring antibody binding doesn't interfere with cell viability or RNA quality

• Data analysis:

  • Require specialized computational approaches to integrate protein and RNA data

  • Background correction algorithms improve data quality by removing non-specific signal

This multimodal approach provides unprecedented resolution of cellular heterogeneity and functional states in S. pombe populations .

What is the optimal fixation and permeabilization protocol for immunofluorescence studies using SPBC216.03 antibody?

For optimal immunofluorescence results with SPBC216.03 antibody:

• Fixation options:

  • Formaldehyde fixation: 3.7% formaldehyde for 30 minutes at room temperature preserves most epitopes while maintaining cell morphology

  • Methanol fixation: -20°C methanol for 6 minutes may provide better accessibility to some nuclear epitopes

  • Combined approach: 3.7% formaldehyde (10 min) followed by -20°C methanol (6 min) often yields optimal results for nuclear proteins like SPBC216.03

• Permeabilization optimization:

  • For formaldehyde-fixed cells, permeabilize with 0.1% Triton X-100 for 5 minutes

  • For challenging nuclear epitopes, increase to 0.5% Triton X-100 or add brief treatment with 1% SDS

  • Enzymatic digestion of cell wall with zymolyase (100T, 1mg/ml for 10 minutes) before permeabilization improves antibody access

• Blocking conditions:

  • Use 3-5% BSA or 5-10% normal serum in PBS for 30-60 minutes

  • Include 0.1% Tween-20 in blocking and antibody incubation buffers

  • For high background, add 5% non-fat dry milk to blocking solution

• Antibody incubation:

  • Primary antibody: Incubate at 1:100-1:500 dilution overnight at 4°C

  • Secondary antibody: Fluorophore-conjugated at 1:500-1:1000 for 1 hour at room temperature

  • Include DAPI (1 μg/ml) for nuclear counterstaining

These optimized protocols maximize signal specificity while minimizing background for SPBC216.03 visualization in S. pombe cells .

What are the critical parameters for Western blot detection of SPBC216.03?

Successful Western blot detection of SPBC216.03 requires attention to these critical parameters:

• Sample preparation:

  • Lyse cells in buffer containing 50mM Tris-HCl pH 7.5, 120mM KCl, 5mM EDTA, 0.1% NP-40, 10% glycerol

  • Disrupt cell suspensions with glass beads using three 30-second pulses in a bead beater at 4.5 setting

  • Include protease inhibitors and phosphatase inhibitors if phosphorylation state is relevant

• Protein separation:

  • Use 12% SDS-PAGE for optimal resolution of SPBC216.03

  • Load 30μg of protein extract per lane for standard detection

  • Include molecular weight markers appropriate for the expected size

• Transfer conditions:

  • Transfer to nitrocellulose membranes (such as Protran) using semi-dry or wet transfer systems

  • For standard sized proteins, transfer at 100V for 1 hour or 30V overnight

• Blocking and antibody incubation:

  • Block in 5% non-fat milk in TBST for 1 hour at room temperature

  • Primary antibody: 1:1000 dilution in blocking buffer, overnight at 4°C

  • Secondary antibody: HRP-conjugated anti-species antibody at 1:5000, 1 hour at room temperature

• Signal detection optimization:

  • Enhanced chemiluminescence (ECL) provides suitable sensitivity for most applications

  • For weaker signals, consider enhanced ECL substrates or fluorescent secondary antibodies

  • Exposure times should be optimized based on signal strength (typically 30 seconds to 5 minutes)

Following these parameters ensures consistent and specific detection of SPBC216.03 in S. pombe lysates .

How can epitope accessibility be improved when using SPBC216.03 antibody in fixed yeast cells?

Improving epitope accessibility for SPBC216.03 antibody requires specific strategies for S. pombe cells:

• Cell wall digestion optimization:

  • Enzymatic approach: Treat with zymolyase 100T (1mg/ml) for 15-30 minutes at 30°C

  • Monitor spheroplast formation microscopically

  • Stop digestion with addition of ice-cold buffer containing 1M sorbitol

• Heat-mediated antigen retrieval:

  • For formaldehyde-fixed samples, heat in citrate buffer (pH 6.0) at 95°C for 10 minutes

  • Allow gradual cooling to room temperature before proceeding

  • This is especially effective for nuclear antigens like SPBC216.03

• Chemical-based antigen retrieval:

  • Treat fixed cells with 0.1-1% SDS for 5 minutes to partially denature proteins

  • Alternatively, use 6M urea or 4M guanidine HCl for 10 minutes

  • Wash extensively to remove all denaturing agents before antibody incubation

• Detergent combination approach:

  • Sequential treatment with multiple detergents (Triton X-100, saponin, and digitonin)

  • Each detergent targets different membrane components

  • Example protocol: 0.1% Triton X-100 (10 min) → 0.05% saponin (5 min) → 0.01% digitonin (5 min)

• Extended incubation periods:

  • Primary antibody incubation for 48-72 hours at 4°C with gentle agitation

  • Use higher antibody concentrations (1:50 - 1:100) for challenging epitopes

These approaches significantly improve SPBC216.03 detection in fixed yeast cells by enhancing antibody accessibility to target epitopes .

What are the considerations for using SPBC216.03 antibody in bispecific antibody engineering applications?

When considering SPBC216.03 antibody for bispecific antibody engineering:

• Domain arrangement impact:

  • The arrangement of variable domains significantly affects activity, with LH-type configurations (VL at N-terminus of VH) potentially showing 1000-fold greater activity than HL-type configurations

  • This "activity enhancement" through domain rearrangement should be systematically evaluated for SPBC216.03-derived bispecific antibodies

• Flexible linker design:

  • Optimize linker length and composition between SPBC216.03 binding domains

  • Glycine-serine repeats (GGGGS)n provide flexibility while maintaining solubility

  • The optimal linker length depends on the distance between binding epitopes

• Expression system selection:

  Expression System	Advantages	Limitations
  E. coli	Cost-effective, rapid	Limited post-translational modifications
  Mammalian cells	Proper folding, glycosylation	Higher cost, longer production time
  Yeast (S. cerevisiae)	Eukaryotic processing, scalable	Different glycosylation patterns
  Insect cells	Good for complex designs	Moderate cost, specialized expertise

• Functional characterization requirements:

  • Test both simultaneous binding capacity to dual targets

  • Evaluate structural integrity using techniques like cryo-EM

  • Assess dynamics between the two binding domains

  • Compare activity between different domain arrangements

• Potential applications:

  • Creating bispecific molecules that target both SPBC216.03 and another protein of interest

  • Developing research tools to study protein-protein interactions in S. pombe

  • Engineering detection reagents for complex experimental setups

Understanding these considerations enables rational design of functional bispecific antibodies incorporating SPBC216.03 binding domains .

What are common sources of background signal when using SPBC216.03 antibody and how can they be mitigated?

Background signal issues with SPBC216.03 antibody can be addressed through systematic optimization:

• Common background sources and solutions:

  Source of Background	Mitigation Strategy
  Non-specific binding	Increase blocking agent concentration (5-10% BSA or serum)
  Excessive antibody concentration	Titrate antibody to optimal concentration; often 1/10 of recommended concentration maintains signal while reducing background
  Cell autofluorescence	Include quenching step (0.1M NH₄Cl for 15 min) before blocking
  Cross-reactivity	Pre-adsorb antibody with cell lysate from SPBC216.03 deletion strain
  Insufficient washing	Increase wash duration and number of washes; add 0.1-0.5% Tween-20

• Optimizing signal-to-noise ratio:

  • Reducing staining volume only affects antibodies targeting abundant epitopes used at low concentrations

  • When reducing staining volume, counteract by reducing cell numbers to 10⁵-10⁶ per reaction

  • Background signal can account for a major fraction of total sequencing in oligo-conjugated applications and is primarily derived from antibodies used at high concentrations

• Application-specific approaches:

  • For immunofluorescence: Add 0.1% Triton X-100 to antibody dilution buffer

  • For Western blot: Use 5% non-fat milk in TBST for blocking

  • For immunoprecipitation: Pre-clear lysates with Protein A/G beads before adding antibody

  • For CITE-seq/oligo-conjugated applications: Drastically reduce antibody concentration without loss of biological information

• Controls for distinguishing specific from non-specific signal:

  • Include isotype control antibody at same concentration

  • Include samples from SPBC216.03 deletion strains

  • Perform peptide competition assays with immunizing peptide

These strategies significantly improve data quality by enhancing specific signal while minimizing background noise .

How can SPBC216.03 antibody specificity be validated in cross-species applications?

Validating SPBC216.03 antibody specificity across species requires systematic approaches:

• Cross-species epitope conservation analysis:

  • Perform sequence alignment of SPBC216.03 homologs from related species

  • Identify conserved and variable regions within the immunizing epitope

  • Predict cross-reactivity based on epitope conservation percentage

• Experimental validation strategy:

  • Western blot validation: Test antibody against lysates from multiple species

  • Knockout/knockdown controls: Include genetic deletion or RNAi samples when available

  • Peptide competition: Pre-incubate antibody with immunizing peptide before application

  • Orthogonal detection methods: Confirm results using tagged protein versions or mass spectrometry

• Recommended cross-species validation workflow:

  Species	Recommended Validation Approach
  S. pombe	Compare wild-type vs. SPBC216.03Δ strains
  S. cerevisiae	Test against wild-type and closest homolog deletion
  Other fungi	Begin with Western blot, confirm with immunoprecipitation
  Mammalian cells	Not recommended without extensive validation

• Quantitative assessment metrics:

  • Signal ratio between wild-type and deletion samples (should exceed 10:1)

  • Detection of correctly sized protein band

  • Consistent subcellular localization pattern

  • Reproducible results across multiple experimental conditions

• Epitope-specific considerations:

  • Polyclonal antibodies may show broader cross-species reactivity

  • Monoclonal antibodies typically offer higher specificity but lower cross-reactivity

  • Custom validation may be required for each new species application

Proper cross-species validation ensures reliable results and prevents misinterpretation when applying SPBC216.03 antibody beyond its original target species .

What strategies can improve detection sensitivity when working with low-abundance forms of SPBC216.03?

For detecting low-abundance forms of SPBC216.03, several specialized approaches can be employed:

• Sample enrichment techniques:

  • Immunoprecipitation before Western blotting

  • Subcellular fractionation to concentrate compartment-specific pools

  • TCA precipitation to concentrate protein from dilute samples

  • For chromatin-associated forms, perform chromatin immunoprecipitation

• Signal amplification methods:

  • Use biotin-streptavidin systems for multi-layer detection

  • Apply tyramide signal amplification (TSA) for immunofluorescence

  • Utilize poly-HRP conjugated secondary antibodies

  • Consider proximity ligation assay (PLA) for detecting protein-protein interactions

• Detection system optimization:

  Detection System	Sensitivity	Best Application
  Standard ECL	Moderate	Routine Western blotting
  Femto ECL substrate	Very high	Low abundance proteins
  Fluorescent secondaries	High, quantitative	Western blot quantification
  Quantum dots	Very high, photostable	Long-exposure imaging

• Instrument settings optimization:

  • Increase exposure time while monitoring background

  • Use cooled CCD cameras for reduced noise in fluorescence imaging

  • Apply deconvolution algorithms to improve signal-to-noise ratio

  • Implement spectral unmixing for multi-labeled samples

• Protocol modifications for low-abundance detection:

  • Extended primary antibody incubation (overnight at 4°C or up to 72 hours)

  • Reduced washing stringency (lower salt concentration, shorter wash times)

  • Use of signal enhancers such as protein-free blockers or background reducers

  • Sequential detection with multiple antibodies targeting different epitopes

These strategies can significantly improve detection of low-abundance SPBC216.03 forms that may be functionally important but challenging to detect with standard protocols .

How should researchers address contradictory results between different detection methods using SPBC216.03 antibody?

When faced with contradictory results between different detection methods:

• Systematic comparison of methodologies:

  • Create a comparison matrix of all methods used (Western blot, IF, ChIP, etc.)

  • Document key variables: antibody concentration, buffers, detection systems

  • Identify pattern of contradictions (e.g., positive by Western but negative by IF)

• Epitope accessibility assessment:

  • Different methods expose epitopes differently

  • Denatured epitopes (Western blot) vs. native epitopes (IP)

  • Fixed vs. live cell detection can yield different results

  • Consider epitope masking by protein-protein interactions

• Validation through orthogonal approaches:

  • Generate tagged versions of SPBC216.03 (HA, FLAG, GFP)

  • Compare antibody results with tag detection results

  • Implement genetic approaches (deletion strains, complementation)

  • Use mass spectrometry for definitive identification

• Common sources of method-specific contradictions:

  Method Combination	Common Contradiction	Potential Resolution
  Western blot vs. IF	Positive WB, negative IF	Optimize fixation/permeabilization for IF
  ChIP vs. IF	Different localization patterns	Check for dynamic relocalization under experimental conditions
  IP vs. Western	Successful IP but weak WB	IP enriches low-abundance forms; adjust WB exposure
  Native vs. denatured detection	Different results	Epitope may be conformationally sensitive; use multiple antibodies

• Documentation and reporting standards:

  • Report all experimental conditions in detail

  • Document both positive and negative results

  • Consider multiple antibodies targeting different epitopes of SPBC216.03

  • Clearly state limitations of each detection method

By systematically addressing contradictions through these approaches, researchers can develop a more complete and accurate understanding of SPBC216.03 biology .